Novo Nordisk A/S

NOV.DE·XETRA·Healthcare
Compare
35.43+0.51 (+1.46%)today
At close: Oct 22, 5:35 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close34.92
Open34.97
Day range34.9235.47
52-week range30.2454.87
Off day high−0.11%
Off 52-week high−35.43%
Volume102.71K
Avg. volume (3M)173.34K
Market cap156.36B
EPS (TTM)3.53
Forward P/E—
P/E ratio (TTM)10.04
Dividend yield4.49% (1.57)
Beta (5Y)0.38
Shares outstanding3.34B
Short interest—
Earnings dateNov 4, 2026
Analyst target—
Profit margin35.35%

Against its peers

Compare in full ›
NOV.DE NVS LLY AZN PFE BMY
Market cap 156.36B 297.02B 1.17T 267.64B 173.38B 128.69B
P/E (TTM) 10.0 23.6 43.9 25.8 40.0 13.9
Forward P/E — 15.9 27.7 15.2 10.5 9.5
Price/book 5.3 7.1 34.4 5.3 2.0 5.8
Dividend yield 4.49% 3.08% 0.54% 1.90% 5.76% 4.12%
1-year change −23.92% +16.93% +54.77% +0.99% +21.00% +39.45%
Today +1.46% +1.52% +2.83% +2.45% +1.91% +3.08%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Latest news

All NOV.DE news ›
Stock Titan·Positive

Novo Nordisk A/S - share repurchase programme

Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP) OpenWorld (NASDAQ: OPNW) Signs Definitive Merger…

MarketScreener·

Novo Nordisk A/S : Insider Transactions

Follow insider transactions on Novo Nordisk A/S in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Novo Nordisk A/S Latest insider transactions for Novo Nordisk A/S All…

MarketScreener·Negative

Novo Nordisk A/S : JP Morgan is Neutral

Published on 10/05/2026 at 07:45 am EDT Novo Nordisk and Eli Lilly trade blows September 29, 2026 at 09:34 am EDT Novo Nordisk: Aiming below the mark Novo Sues Rival Lilly Over Weight-Loss Ads

MarketScreener·Positive

Novo Nordisk A/S: Relative Strength Chart - Stock Nasdaq Copenhagen

Compare Novo Nordisk A/S with the company of your choice via a Relative Strength chart. Real-time NOVO B price, Nasdaq Copenhagen stock exchange Relative Strength Chart Novo Nordisk A/S All financial news and data tailored to specific…

MarketScreener·Negative

Novo Nordisk A/S : Deutsche Bank gives a Sell rating

Published on 10/07/2026 at 03:28 am EDT Novo Nordisk and Eli Lilly trade blows September 29, 2026 at 09:34 am EDT Novo Nordisk: Aiming below the mark Novo Sues Rival Lilly Over Weight-Loss Ads

From articles in the 4Search news index.

In the news

26mentions in 30 days
26with it in the headline
Mixedsentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 26 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.